Phathom Pharmaceuticals Files Form 10-Q for Quarter Ended Sept. 30
Phathom Pharmaceuticals filed a Form 10-Q for the period ended Sept. 30.
Related stories
Hang Seng Tech Index Opens 0.6% Lower at 3720.49
M impact | EQUITY | Oct 30, 2026, 01:22 AM UTC
JPMorgan Initiates Palantir Coverage With Overweight Rating, $262 Target
JPMorgan initiated research coverage of Palantir with an overweight rating and a $262 12-month price target, 33% above Wednesday’s level.
M impact | EQUITY | Oct 30, 2026, 01:22 AM UTC
Novatti Group Reports Quarterly Revenue of A$6.9 Million
Novatti Group reported quarterly group revenue of A$6.9 million.
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
Hang Seng Index Opens 0.2% Higher at 23011.29
L impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
X2M Connect Secures A$1.4M for Data Centre and AI Strategy
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC
X2M Connect Secures A$1.4 Million for Data Centre and AI Strategy
M impact | EQUITY | Oct 30, 2026, 01:21 AM UTC